Automatic inactivation system capable of guaranteeing sterility of concentrated solution and inactivation effect in vaccine production

A technology for vaccine production and inactivation effect, applied in biochemical instruments, biomass post-processing, biological material pretreatment, etc., can solve the problems of general inactivation effect, inactivation that cannot be automatic, and low efficiency of vaccine inactivation. The effect of improving inactivation efficiency and improving effect

Pending Publication Date: 2019-06-04
NINGBO RONGAN BIOLOGICAL PHARMA
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the existing vaccine production, when inactivating the concentrated solution, the inactivation effect is average, and automatic inactivation cannot be performed, making the inactivation efficiency in vaccine production low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Automatic inactivation system capable of guaranteeing sterility of concentrated solution and inactivation effect in vaccine production
  • Automatic inactivation system capable of guaranteeing sterility of concentrated solution and inactivation effect in vaccine production
  • Automatic inactivation system capable of guaranteeing sterility of concentrated solution and inactivation effect in vaccine production

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention.

[0022] refer to Figure 1-5 An automatic inactivation system to ensure the sterility and inactivation effect of the concentrated solution in vaccine production, comprising a kettle body 1, a motor 5 is arranged below the kettle body 1, and the output shaft of the motor 5 is connected with a motor extending into the kettle body 1 Stirring rod 8, a controller 4 is installed on one side of the kettle body 1, a liquid pipe 7 is connected to the upper part of the kettle body 1, and the other end of the liquid pipe 7 extends into the concentrated liquid tank 2, and the concentrated liquid tank 2 is inserted An air pipe 6 is installed, and an air flow control valve is insta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of vaccine production, in particular to an automatic inactivation system capable of guaranteeing sterility of a concentrated solution and an inactivation effect in vaccine production. The system comprises a kettle body and a concentrated solution tank, a motor is arranged below the kettle body, an output shaft of the motor is connected with a stirring rod extending into the kettle body, a controller is mounted on one side of the kettle body, the upper part of the kettle body communicates with a solution pipe, the other end of the solution pipe extends into the concentrated solution tank, the inside of the concentrated solution tank communicates with an air pipe, a charging machine is fixed and mounted at the top end of the kettle body and comprises a fixed cover and an electric push rod, a push rod end of the electric push rod is fixedly connected with a solution storage box, a solution inlet groove is formed in one side of the upper end ofthe solution storage box, a solution addition tank is fixed and mounted in the fixed cover through a support, the bottom end of the solution addition tank communicates with a solution discharge pipe extending into the solution inlet groove, the top end of the solution addition tank is connected with a solution inlet pipe and an automatic solution addition pipe, so that automatic and efficient inactivation can be realized in the whole inactivation process, the inactivation efficiency is improved, and the inactivation effect is improved.

Description

technical field [0001] The invention relates to the technical field of vaccine production, in particular to an automatic inactivation system for ensuring the sterility and inactivation effect of concentrated liquid in vaccine production. Background technique [0002] Inactivated vaccines refer to culturing viruses or bacteria and then inactivating them with heat or chemicals. Inactivated vaccines can be composed of whole viruses or bacteria, or their split fragments as split vaccines. Inactivated vaccines are usually not affected by circulating antibodies and can be administered even if antibodies are present in the blood. They cannot replicate in the body and can be used in immunocompromised persons. At present, the inactivated vaccines used in my country include DPT vaccine, influenza vaccine, rabies vaccine and hepatitis A inactivated vaccine. In the existing vaccine production, when inactivating the concentrated solution, the inactivation effect is average, and automat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12M1/36C12M1/02C12M1/00
Inventor 胡德东陈猛喻志远曹金良
Owner NINGBO RONGAN BIOLOGICAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap